HEPATOBILIARY CANCER
Clinical trials for HEPATOBILIARY CANCER explained in plain language.
Never miss a new study
Get alerted when new HEPATOBILIARY CANCER trials appear
Sign up with your email to follow new studies for HEPATOBILIARY CANCER, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New drug duo takes on tough liver cancers
Disease control OngoingThis study tests whether combining two drugs, domvanalimab and zimberelimab, can shrink or control advanced liver and bile duct cancers that have stopped responding to earlier treatments. About 58 adults with these cancers will receive the drug combination. The main goal is to se…
Matched conditions: HEPATOBILIARY CANCER
Phase: PHASE2 • Sponsor: University of Texas Southwestern Medical Center • Aim: Disease control
Last updated Jun 22, 2026 12:09 UTC
-
Gentle exercise before cancer surgery: a feasibility test for seniors
Knowledge-focused OngoingThis study looks at whether a home-based exercise program is practical and safe for people aged 65 and older who are waiting for liver or bile duct cancer surgery. About 25 participants will do supervised exercise sessions and be tracked for how many join, stick with it, and repo…
Matched conditions: HEPATOBILIARY CANCER
Phase: NA • Sponsor: H. Lee Moffitt Cancer Center and Research Institute • Aim: Knowledge-focused
Last updated Jun 12, 2026 12:03 UTC